Suyash Prasad
Senior VP & Chief Med Officer, Audentes Therapeutics, Inc.
Companies
- Taysha Gene Therapies, Inc.CMO and Head of R&D Sep 23, 2020 to Jul 7, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Taysha Gene Therapies, Inc. TSHA530,589 shares2$2.0M at $3.77Jul 6, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 6, 2022Sold 8,956 shares at $3.79 of Taysha Gene Therapies, Inc.2
- Jul 5, 2022Sold 3,905 shares at $3.51 of Taysha Gene Therapies, Inc.2
- Jul 1, 2022Sold 23,923 shares at $3.53 of Taysha Gene Therapies, Inc.3
- Jun 30, 2022Sold 13,892 shares at $3.72 of Taysha Gene Therapies, Inc.3
- Jun 29, 2022Sold 12,324 shares at $3.81 of Taysha Gene Therapies, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jul 1, 2022